ClinicalTrials.govpublic full text
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
cutaneous melanoma, non-small cell lung cancer, squamous cell carcinoma of the head and neck, urothelial carcinoma, renal cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 454035
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.